Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
First Claim
1. A transgenic ungulate whose cells comprise one or more artificial chromosomes, each artificial chromosome comprising one or more xenogenous immunoglobulin heavy or light chain loci that undergo rearrangement and are expressed in B cells to produce xenogenous immunoglobulin in response to exposure to one or more antigens.
11 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the production of a transgenic bovine which comprises a genetic modification that results in inactivation and loss of expression of its endogenous antibodies, and the expression of xenogenous antibodies, preferably human antibodies. This is effected by inactivation of the IgM heavy chain expression and, optionally, by inactivation of the Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of non-bovine antibodies, preferably human antibodies.
-
Citations
36 Claims
- 1. A transgenic ungulate whose cells comprise one or more artificial chromosomes, each artificial chromosome comprising one or more xenogenous immunoglobulin heavy or light chain loci that undergo rearrangement and are expressed in B cells to produce xenogenous immunoglobulin in response to exposure to one or more antigens.
- 13. An isolated ungulate somatic cell comprising one or more artificial chromosomes, each artificial chromosome comprising one or more xenogenous immunoglobulin heavy or light chain loci that undergo rearrangement and are expressed in B cells to produce xenogenous immunoglobulin in response to exposure to one or more antigens.
-
26. A method of producing xenogenous antibodies against one or more antigens, said method comprising the steps of:
-
(a) administering one or more antigens to a transgenic ungulate whose cells comprise one or more artificial chromosomes, each artificial chromosome comprising one or more xenogenous immunoglobulin heavy or light chain loci that undergo rearrangement and are expressed in B cells to produce xenogenous immunoglobulin, resulting in the production of xenogenous antibodies against said one or more antigens; and (b) recovering said xenogenous antibodies from said ungulate. - View Dependent Claims (28, 29, 30, 31, 32, 33, 34, 35, 36)
-
-
27. A method of producing xenogenous antibodies against one or more antigens, said method comprising recovering xenogenous antibodies from a transgenic ungulate whose cells comprise one or more artificial chromosomes, each artificial chromosome comprising one or more xenogenous immunoglobulin heavy or light chain loci that undergo rearrangement and are expressed in B cells, resulting in production of xenogenous antibodies against said one or more antigens.
Specification